Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Oncogene ; 33(1): 74-84, 2014 Jan 02.
Article in English | MEDLINE | ID: mdl-23178499

ABSTRACT

Leptin acts on its receptor (ObR) in the hypothalamus to inhibit food intake and energy expenditure. Leptin and ObR are also expressed in the gastrointestinal tract; however, the physiological significance of leptin signaling in the gut remains uncertain. Suppressor of cytokine signaling 3 (SOCS3) is a key negative feedback regulator of ObR-mediated signaling in the hypothalamus. We now show that gastrointestinal epithelial cell-specific SOCS3 conditional knockout (T3b-SOCS3 cKO) mice developed gastric tumors by enhancing leptin production and the ObRb/signal transducer and activator of transcription 3 (STAT3) signaling pathway. All T3b-SOCS3 cKO mice developed tumors in the stomach but not in the bowels by 2 months of age, even though the SOCS3 deletion occurred in both the epithelium of stomach and bowels. The tumors developed in the absence of the inflammatory response and all cKO mice died within 6 months. These tumors displayed pathology and molecular alterations, such as an increase in MUC2 (Mucin 2, oligomeric mucus/gel-forming) and TFF3 (trefoil factor 3), resembling human intestinal-type gastric tumors. Administration of antileptin antibody to T3b-SOCS3 cKO mice reduced hyperplasia of gastric mucosa, which is the step of the initiation of gastric tumor. These data suggest that SOCS3 is an antigastric tumor gene that suppresses leptin overexpression and ObRb/STAT3 hyperactivation, supporting the hypothesis that the leptin/ObRb/STAT3 axis accelerates tumorigenesis and that it may represent a new therapeutic target for the treatment of gastric cancer.


Subject(s)
Adenocarcinoma/metabolism , Receptors, Leptin/metabolism , Stomach Neoplasms/metabolism , Suppressor of Cytokine Signaling Proteins/deficiency , Adenocarcinoma/drug therapy , Animals , Antibodies/administration & dosage , Antineoplastic Agents/administration & dosage , Carcinogenesis/metabolism , Cells, Cultured , Disease Models, Animal , Drug Evaluation, Preclinical , Gastric Mucosa/metabolism , Humans , Injections, Intraperitoneal , Intestinal Mucosa/metabolism , Leptin/antagonists & inhibitors , Leptin/immunology , Mice , Mice, Transgenic , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/metabolism , Protein Kinases/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Stomach/pathology , Stomach Neoplasms/drug therapy , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics
2.
Mucosal Immunol ; 6(6): 1131-42, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23462911

ABSTRACT

Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), a TNF superfamily member, induces damage of the epithelial cells (ECs) and production of inflammatory mediaters through its receptor Fn14 in a model of acute colitis. In our current study of chronic colitis induced by repeated rectal injection of a hapten, we found that inflammation, fibrosis, and T helper 2 (Th2)-type immunity were significantly reduced in Fn14 gene knockout (KO) mice when compared with wild-type (WT) control mice. Expression of thymic stromal lymphopoietin (TSLP) was lower in Fn14 KO colon ECs than in WT ECs. TWEAK potentiates the induction of TSLP by interleukin-13 (IL-13) in colon explants from WT but not in Fn14 KO tissue. TSLP receptor KO mice exhibit milder chronic colitis, similar to that in Fn14 KO mice. TWEAK and IL-13 synergistically promote fibroblast proliferation. Thus we propose an IL-13-TWEAK/Fn14-TSLP axis as a key mechanism underlying chronic colitis with fibrosis.


Subject(s)
Colitis/immunology , Colon/pathology , Fibroblasts/immunology , Interleukin-13/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Th2 Cells/immunology , Tumor Necrosis Factors/metabolism , Animals , Cell Proliferation , Cells, Cultured , Chronic Disease , Colitis/chemically induced , Cytokine TWEAK , Disease Models, Animal , Female , Fibrosis , Humans , Immunoglobulins/genetics , Immunoglobulins/metabolism , Interleukin-13/immunology , Mice , Mice, Inbred BALB C , Mice, Knockout , Organ Culture Techniques , Receptors, Cytokine/genetics , Receptors, Cytokine/metabolism , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/immunology , TWEAK Receptor , Trinitrobenzenesulfonic Acid/administration & dosage , Tumor Necrosis Factors/immunology
3.
Gut ; 55(2): 212-9, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16120757

ABSTRACT

BACKGROUND AND AIMS: Imbalance between pro- and anti-inflammatory cytokines produced by intestinal T cells induces inflammatory bowel diseases (IBD). However, the importance of regulation of cytokine signalling in IBD has not been fully clarified. We have demonstrated that suppressor of cytokine signalling 1 (SOCS1) is expressed in inflamed tissues in an experimental colitis model. In the present study, we investigated the role of SOCS1 in colitis models to clarify the mechanism of IBD development. METHODS: Intestinal T cells in transgenic mice expressing high levels of SOCS1 in lymphocytes (SOCS1Tg mice) were characterised by flow cytometric analysis and cytokine production from intestinal T cells was determined by ELISA. 2,4,6-Trinitrobenzene sulphonic acid (TNBS) induced colitis was induced in SOCS1Tg mice and severity was compared with control littermates by measurement of survival rates. Intracellular signalling was assessed by western blotting analysis. RESULTS: SOCS1Tg mice developed colitis spontaneously with age. Young SOCS1Tg mice less than 15 weeks of age, before the onset of colitis, were susceptible to TNBS induced colitis. Intestinal T cells of SOCS1Tg mice showed increased interferon gamma and tumour necrosis factor alpha production and decreased transforming growth factor beta production. Expression of cytotoxic T lymphocyte associated antigen 4 (CTLA-4), a negative regulator of T cell activation, in SOCS1Tg mice was severely impaired at the protein level although mRNA levels of CTLA-4 in SOCS1Tg mice were comparable with those in control mice. CONCLUSIONS: Our data suggest that SOCS1 plays an important role in the regulation of colitis by controlling intestinal T cell activation mediated through CTLA-4 expression.


Subject(s)
Carrier Proteins/immunology , Inflammatory Bowel Diseases/immunology , Lymphocytes/immunology , Repressor Proteins/immunology , Suppressor of Cytokine Signaling Proteins/immunology , Animals , Antigens, CD , Antigens, Differentiation/immunology , CTLA-4 Antigen , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cells, Cultured , Cytokines/biosynthesis , Disease Models, Animal , Down-Regulation/immunology , Gene Expression Regulation/immunology , Immunophenotyping , Lymphocyte Activation/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Repressor Proteins/genetics , Repressor Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism , T-Lymphocyte Subsets/immunology
4.
Article in English | MEDLINE | ID: mdl-12687406

ABSTRACT

Immune and inflammatory systems are controlled by multiple cytokines, including interleukins (ILs) and interferons. These cytokines exert their biological functions through Janus tyrosine kinases (JAKs) and STAT transcription factors. The CIS (cytokine-inducible SH2 protein) and SOCS (suppressors of cytokine signaling) are a family of intracellular proteins, several of which have emerged as key physiological regulators of cytokine responses, including those that regulate the inflammatory systems. In this review, we focused on the molecular mechanism of the action of CIS/SOCS family proteins and their roles in inflammatory diseases. Furthermore, we illustrate several approaches for treating inflammatory diseases by modulating extracellular and intracellular signaling pathways.


Subject(s)
Cytokines/physiology , Immediate-Early Proteins/physiology , Inflammation/etiology , Intracellular Signaling Peptides and Proteins , Repressor Proteins/physiology , Animals , Carrier Proteins/physiology , Humans , Immediate-Early Proteins/chemistry , Inflammation/physiopathology , Membrane Glycoproteins/physiology , Mice , Models, Biological , Receptors, Cell Surface/physiology , Repressor Proteins/chemistry , Signal Transduction , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins , T-Lymphocytes/immunology , Toll-Like Receptors , Transcription Factors/physiology
5.
Arch Virol ; 147(1): 187-94, 2002.
Article in English | MEDLINE | ID: mdl-11855631

ABSTRACT

We studied the requirement for CD40+ cells in the resolution of vaginal infection with avirulent herpes simplex virus type I (HSV-1) in vivo using CD40-deficient mice, which were susceptible to infection with avirulent HSV-1. Compared with wild-type mice, CD40-deficient mice could not eliminate HSV-1 virus effectively from the vaginal mucosa and produced lower amounts of interleukin-12 and interferon-gamma. These results show that the induction and activation of CD40+ cells are important for HSV prevention, facilitating the activation of T cells to induce an efficient HSV clearance from the vaginal mucosa and to prevent lethal illness due to HSV infection.


Subject(s)
CD40 Antigens/immunology , Herpes Genitalis/immunology , Herpesvirus 1, Human/immunology , Vaginal Diseases/immunology , Animals , Cytokines/biosynthesis , Disease Models, Animal , Female , Herpes Genitalis/physiopathology , Herpes Genitalis/prevention & control , Herpes Genitalis/virology , Herpesvirus 1, Human/isolation & purification , Humans , Lymphocyte Activation , Mice , Mice, Inbred BALB C , T-Lymphocytes/immunology , Vagina/virology , Vaginal Diseases/physiopathology , Vaginal Diseases/prevention & control , Vaginal Diseases/virology
6.
Vaccine ; 20(1-2): 98-104, 2001 Oct 12.
Article in English | MEDLINE | ID: mdl-11567752

ABSTRACT

We investigated the effects of US2 and US3 deficiencies of herpes simplex virus type 2 (HSV-2) on host immunity in a murine model of genital herpes infection. Viral clearance from the vaginal mucosa was more rapid in mice infected with a US3-deficient mutant L1BR1 as compared with a wild-type 186 or YY2 (US2-deficient mutant) infection, although there was no significant difference among them in initial growth in the early stage of infection. Flow cytometric studies revealed that the number of vaginal mononuclear cells in L1BR1-infected mice was significantly greater than that in 186- or YY2-infected mice. Dendritic cells, macrophages and T cells were induced more rapidly and in greater numbers within the vaginas of L1BR1-infected mice. Moreover, the levels of IL-12 and IFN-gamma increased in L1BR1-infected mice over levels in 186-infected mice. These results indicate that a US3 deficiency alters the induction of the host immune response; therefore, the inactivation of US3 may be a promising strategy in the development of novel vaccines for genital herpes.


Subject(s)
Herpes Genitalis/virology , Herpesvirus 2, Human/pathogenicity , Protein Serine-Threonine Kinases/physiology , Vagina/immunology , Viral Envelope Proteins/physiology , Administration, Intravaginal , Animals , Antigen Presentation , Dendritic Cells/immunology , Female , Herpes Genitalis/pathology , Herpesvirus 2, Human/genetics , Herpesvirus 2, Human/physiology , Interferon-gamma/metabolism , Interleukin-12/metabolism , Interleukin-4/metabolism , Lymphocyte Activation , Macrophage Activation , Macrophages/immunology , Mice , Mice, Inbred BALB C , Mucous Membrane/pathology , Mucous Membrane/virology , Protein Serine-Threonine Kinases/deficiency , Protein Serine-Threonine Kinases/genetics , Sequence Deletion , T-Lymphocyte Subsets/immunology , Vagina/pathology , Vagina/virology , Viral Envelope Proteins/deficiency , Viral Envelope Proteins/genetics , Viral Proteins , Virus Replication
7.
Cell Immunol ; 208(2): 88-95, 2001 Mar 15.
Article in English | MEDLINE | ID: mdl-11333141

ABSTRACT

Intestinal intraepithelial lymphocytes (i-IEL) readily undergo spontaneous apoptosis in vitro through an unclear mechanism. Here we examined the relationship between caspases, which plays a major role in apoptosis, and IL-7 in the spontaneous apoptosis of i-IEL in vitro. We demonstrated that IL-7 and zVAD prevented the spontaneous apoptosis of i-IEL by approximately 50% and 25% respectively with no additive protection seen when both are used. IL-7 preferentially prevented the apoptosis of gammadelta i-IEL, while zVAD equally prevented the apoptosis of gammadelta and alphabeta i-IEL. Lastly, we demonstrated that the spontaneous apoptosis of i-IEL is associated with a marked increase in caspase activity. Caspase activity was completely inhibited by zVAD, but only slightly by IL-7. Overall these results suggest that two pathways lead to the spontaneous apoptosis of i-IEL, one which is caspase dependent and the other which is caspase independent. IL-7 appears to exert its effect on i-IEL undergoing spontaneous by partially inhibiting both apoptotic pathways.


Subject(s)
Apoptosis/immunology , Caspases/immunology , Interleukin-7/immunology , Intestinal Mucosa/immunology , Signal Transduction/immunology , T-Lymphocytes/immunology , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Caspase 3 , Caspases/metabolism , Down-Regulation/immunology , Immunity, Mucosal/immunology , Interleukin-15/immunology , Interleukin-15/pharmacology , Interleukin-7/pharmacology , Intestinal Mucosa/cytology , Mice , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/immunology , Mitochondria/physiology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/drug effects
8.
Oncogene ; 20(7): 812-8, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11314015

ABSTRACT

Radiation induces apoptosis of crypt intestinal epithelial cells (IEC) through a pathway that is largely dependent on p53. However, exactly how p53 mediates IEC apoptosis is unclear. Studies in vitro suggest that one mechanism by which p53 mediates apoptosis is through its ability to transactivate members of the TNF receptor family of 'Death Receptors'. Here, we examined the role of one of its member, TNF receptor type 1 (TNFR1), in an in vivo model of p53-dependent radiation-induced IEC apoptosis. We demonstrate that mice genetically engineered to be deficient in TNF receptor type 1 (TNFR1(-/-)) and mice injected with TNFR1-fusion chimeric protein (TNFR1-Fc; a competitive inhibitor of TNFR1) were partially protected (30-40%) from p53-dependent radiation-induced IEC apoptosis. However, we found no evidence to support the possibility p53 transcriptionally regulates the expression of TNFR1 nor increases the susceptibility of IEC to TNF-mediated apoptosis. Interestingly, we found that injection of TNF readily induced IEC apoptosis and that radiation induced a p53-dependent increase in the intestinal level of TNF. Furthermore, injection of a neutralizing anti-TNF mAb reduced p53-dependent radiation-induced IEC apoptosis by approximately 60%. Overall, these results suggest that p53-dependent radiation-induced IEC apoptosis is mediated in part through ability of p53 to regulate TNF, which subsequently induces IEC apoptosis through TNFR1.


Subject(s)
Antigens, CD/metabolism , Apoptosis , Intestinal Mucosa/radiation effects , Intestine, Small/radiation effects , Receptors, Tumor Necrosis Factor/metabolism , Tumor Necrosis Factor-alpha/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Dose-Response Relationship, Drug , Gamma Rays , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Receptors, Tumor Necrosis Factor, Type I , Signal Transduction , Tumor Necrosis Factor-alpha/pharmacology , Tumor Suppressor Protein p53/genetics
9.
Arch Virol ; 145(10): 1989-2002, 2000.
Article in English | MEDLINE | ID: mdl-11087087

ABSTRACT

We investigated the immune events in the vagina of mice intravaginally infected with highly virulent herpes simplex virus type 2 (HSV-2) strain 186, and compared them with those induced by HSV type 1 strain KOS, a widely known laboratory strain. Although there was no significant difference between 186 and KOS in the viral replication in the initial stage of infection, inadequate and delayed clearance of virus from the vaginal mucosa was observed in 1 86-challenged mice. The induction of antigen-presenting cells (APC) such as dendritic cells (DC) and macrophages (Mphi) in the vagina was slow in 186-challenged mice, and the number of T cells in the vagina in 186-challenged mice was much lower than that in KOS-challenged mice. Furthermore, the level of IL-12 as well as that of IFN-gamma was significantly lower in 186-challenged mice than in KOS-challenged mice, while the level of IL-4 in 186-challenged mice was higher than that in KOS-challenged mice. On the basis of these observations, we suggest that the weak activation of epithelial cells and the delayed induction of APC by 186-infection may be involved in the inadequate activation of T cells and the ineffective virus clearance from the vaginal mucosa.


Subject(s)
Herpes Genitalis/immunology , Herpesvirus 2, Human/immunology , Herpesvirus 2, Human/pathogenicity , Vagina/immunology , Animals , Antigen-Presenting Cells/immunology , Cytokines/metabolism , Disease Models, Animal , Epithelial Cells/immunology , Epithelial Cells/metabolism , Female , Herpes Genitalis/virology , Herpes Simplex/virology , Herpesvirus 1, Human/immunology , Herpesvirus 1, Human/pathogenicity , Ilium/immunology , Lymph Nodes/immunology , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Mucous Membrane/immunology , Mucous Membrane/pathology , Mucous Membrane/virology , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Vagina/pathology , Vagina/virology
10.
J Gen Virol ; 81(Pt 2): 401-6, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10644838

ABSTRACT

In this study, mitochondria migrated to a perinuclear region in the cytoplasm in herpes simplex virus (HSV)-infected cells. HSV infection did not promote the expression of cytochrome c oxidase subunit 2 but did promote that of stress-responsive HSP60, both of which are known to be components of mitochondria. The levels of cellular ATP and lactate and mitochondrial membrane potential were maintained for at least 6 h but decreased at the late stage of infection. It was also found that the UL41 and UL46 gene products, both of which are known to be tegument proteins, accumulated in the perinuclear region. The clustering of mitochondria and the accumulation of tegument proteins were completely blocked by the addition of nocodazole and vinblastine. These results suggest that mitochondria respond to the stimulation of HSV infection, migrating with tegument proteins along microtubules to a site around the nucleus, and maintain function until at least the middle stage of infection.


Subject(s)
Herpesvirus 1, Human/pathogenicity , Herpesvirus 2, Human/pathogenicity , Mitochondria/physiology , Animals , Cell Line , Chaperonin 60/metabolism , Chlorocebus aethiops , Electron Transport Complex IV/metabolism , Herpes Simplex/pathology , Herpes Simplex/physiopathology , Humans , Microscopy, Confocal , Microtubules/drug effects , Microtubules/physiology , Movement/drug effects , Nocodazole/pharmacology , Vero Cells , Vinblastine/pharmacology
11.
Eur J Immunol ; 27(11): 2885-91, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9394814

ABSTRACT

Several cytokines including stem cell factor (SCF) and interleukin (IL)-7 are known to be required for development of gamma delta T cell receptor (TCR) intestinal intraepithelial lymphocytes (i-IEL) in mice. We show here the effects of IL-15 on the proliferation and maintenance of murine gamma delta i-IEL in vitro. gamma delta i-IEL constitutively expressed a high level of IL-15 receptor alpha mRNA and proliferated in response to IL-15 more vigorously than alpha beta i-IEL. V gamma/delta repertoire analysis revealed that IL-15, like IL-2, induced polyclonal expansion of gamma delta i-IEL, whereas gamma delta i-IEL responding to IL-7 showed a V gamma/delta repertoire skewed towards V gamma 1/V delta 4, V delta 5. IL-15 efficiently prevented gamma delta i-IEL from apoptosis induced by growth factor deprivation. This rescue was accompanied by up-regulation of Bcl-2 expression. These results suggest that IL-15 plays important roles in proliferation and maintenance of gamma delta i-IEL.


Subject(s)
Interleukin-15/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Lymphocyte Subsets/drug effects , Lymphocyte Subsets/metabolism , Receptors, Antigen, T-Cell, gamma-delta , Adjuvants, Immunologic/pharmacology , Animals , Cell Death/drug effects , Cell Division/drug effects , Cell Division/immunology , Clone Cells , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/metabolism , Growth Substances/deficiency , Interleukin-15/deficiency , Intestinal Mucosa/cytology , Lymphocyte Activation/drug effects , Lymphocyte Subsets/cytology , Male , Mice , Mice, Inbred C57BL , Receptors, Antigen, T-Cell, gamma-delta/biosynthesis , Receptors, Antigen, T-Cell, gamma-delta/drug effects , Receptors, Interleukin-2/biosynthesis , Receptors, Interleukin-2/drug effects
12.
Lab Invest ; 77(5): 421-9, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9389785

ABSTRACT

Intestinal epithelial cells (i-EC), which move to the villus tips from the crypts, rapidly die by apoptosis at the villus tips and are perpetually renewed at the crypts. To determine whether the Fas antigen (Fas)/Fas ligand (FasL) system is involved in the mechanism leading to apoptosis of i-EC, we examined the expression of Fas and FasL on the i-EC and intestinal intraepithelial lymphocytes (i-IEL) in normal mice. A high level of Fas was expressed on both the i-EC and i-IEL, whereas FasL was expressed in the i-IEL, especially in high-density fraction upon separation (high-density i-IEL), but not in the i-EC. The high-density i-IEL exhibited cytotoxicity against not only Fas transfectant but also the i-EC, and the cytotoxicity was inhibited by addition of Fas-Fragment c chimeric fusion protein. Thus, a significant fraction of i-IEL, such as high-density i-IEL, may partly contribute to induction of apoptosis in the effete i-EC via Fas/FasL interaction.


Subject(s)
Apoptosis/immunology , Epithelial Cells/immunology , Intestine, Small/immunology , Lymphocytes/immunology , Membrane Glycoproteins/metabolism , fas Receptor/metabolism , Animals , Cytotoxicity, Immunologic , Epithelial Cells/metabolism , Fas Ligand Protein , Intestine, Small/cytology , Intestine, Small/metabolism , Ligands , Lymphocytes/metabolism , Male , Membrane Glycoproteins/biosynthesis , Mice , Mice, Inbred C57BL , Transfection/immunology , fas Receptor/biosynthesis
13.
Gastroenterology ; 113(1): 168-74, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9207275

ABSTRACT

BACKGROUND & AIMS: Host-derived intestinal intraepithelial lymphocytes (IELs) increase in number during acute graft-versus-host disease (GVHD) in mice. In the present study, we examined Fas-mediated cytotoxicity by host-derived IELs against Fas-expressing target cells to see whether Fas/Fas ligand (Fas-L) interaction is involved in the pathogenesis of enteropathy during acute GVHD. METHODS: Acute GVHD was induced by injection of parental spleen cells into nonirradiated F1 mice. The expression of Fas antigen on the intestinal epithelial cells (IECs) was examined by flow cytometry, and the expression of messenger RNA (mRNA) for Fas-L, interleukin 2, and interferon gamma in host-derived IELs was assessed by reverse-transcription polymerase chain reaction. Fas-mediated cytotoxicity by host-derived IELs was assessed using Fas-transfected cells, IECs, and Fas immunoglobulin Fc fusion protein (Fas Fc). RESULTS: Fas antigen was constitutively expressed on the cell surface of IECs before and after GVHD induction. Although Fas-L mRNA was not detected or detected scarcely in either alphabeta or gammadelta IELs before GVHD induction, both IELs expressed high levels of mRNA for Fas-L and interferon gamma after GVHD induction. Host-derived IELs during acute GVHD showed cytotoxicity against Fas-transfected target cells and IECs, which was partly blocked by addition of Fas Fc. CONCLUSIONS: Fas/Fas-L-mediated cytotoxicity by host-derived IELs may be partly responsible for the enteropathy during acute GVHD.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cytotoxicity, Immunologic/immunology , Graft vs Host Disease/immunology , fas Receptor/immunology , Animals , Blotting, Southern , Epithelial Cells , Fas Ligand Protein , Female , Flow Cytometry , Graft vs Host Disease/pathology , Intestinal Diseases/immunology , Intestine, Small/cytology , Membrane Glycoproteins/immunology , Mice , Mice, Inbred C57BL , Polymerase Chain Reaction , RNA, Messenger/genetics , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology
14.
Microbiol Immunol ; 41(2): 139-48, 1997.
Article in English | MEDLINE | ID: mdl-9087956

ABSTRACT

To investigate the effect of glucocorticoids on apoptosis in intestinal intraepithelial lymphocytes (i-IEL), we examined the changes of i-IEL followed by in vivo treatment with dexamethasone. The fragmented DNA of i-IEL were significantly increased at 15 hr after dexamethasone treatment and, subsequently, the number of total i-IEL were decreased by day 4 after treatment. Although all subsets of i-IEL including CD8 alpha/alpha(+), CD8 alpha/beta(+), CD4+ and CD4+CD8+ i-IEL were decreased after dexamethasone treatment, CD8 alpha/alpha(+) i-IEL appeared to be relatively resistant to dexamethasone-induced apoptosis. Consistent with the in vivo findings, CD8 alpha/alpha(+) i-IEL exhibited less susceptibility to dexamethasone-induced cell death in vitro than other subsets. To investigate whether this process occurs under physiological conditions, we examined the kinetics of i-IEL after treatment with 15-hr water immersion stress. In mice subjected to water immersion stress, plasma glucocorticoids were remarkably elevated soon after the 15-hr stress. The increase in the fragmented DNA of i-IEL and subsequent decrease in the number of i-IEL were observed in the stressed mice in the same kinetics as seen in the dexamethasone-treated mice. Similar to dexamethasone-induced ell death, CD8 alpha/alpha(+) i-IEL appeared to be relatively resistant to stress-induced apoptosis compared with other i-IEL subsets. The expression level of Bcl-2 was significantly higher in CD8 alpha/alpha(+) i-IEL than in CD8 alpha/beta(+) i-IEL. Our results indicate that i-IEL are subjected to cell death via apoptosis by exogenous and endogenous glucocorticoids and that different sensitivity to steroid-induced apoptosis may exist among i-IEL subsets in relation to their Bcl-2 expression.


Subject(s)
Apoptosis/drug effects , Apoptosis/immunology , Corticosterone/metabolism , Corticosterone/physiology , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Intestine, Small/immunology , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , Animals , CD4 Antigens/analysis , CD8 Antigens/analysis , Corticosterone/blood , DNA Fragmentation , Female , Flow Cytometry , Kinetics , Lymphocyte Count , Mice , Mice, Inbred C57BL , Near Drowning/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Antigen, T-Cell, alpha-beta/analysis , T-Lymphocyte Subsets/immunology , T-Lymphocytes/immunology
15.
Microbiol Immunol ; 41(11): 883-9, 1997.
Article in English | MEDLINE | ID: mdl-9444331

ABSTRACT

We have previously reported that a nonapeptide thymic hormone, facteur thymique serique (FTS), is involved in the differentiation and activation of intestinal intraepithelial lymphocytes (i-IEL) in mice. In this study, we examined the effect of FTS treatment on enteropathy in a murine model for acute graft-vs.-host disease (GVHD) induced by injection of parental C57BL/6 splenocytes into unirradiated (C57BL/6 x DBA/2) F1 hybrids. FTS treatment significantly protected mice from developing acute GVHD as assessed by mortality rate, splenomegaly and enteropathy. The infiltration of donor-derived TCR alpha beta i-IEL bearing CD8 alpha beta was significantly inhibited in the small intestine of FTS-treated mice, and the frequencies of apoptosis of crypt cells in the intestinal mucosa were decreased in these mice during acute GVHD. These results suggest that FTS treatment contributes to protection against enteropathy of acute GVHD. Thus, FTS may provide a useful approach to control acute GVHD after blood transfusion or bone marrow transplantation.


Subject(s)
Graft vs Host Disease/drug therapy , Intestinal Diseases/prevention & control , Intestinal Mucosa/pathology , Intestine, Small/pathology , Thymic Factor, Circulating/therapeutic use , Animals , Apoptosis/drug effects , Female , Flow Cytometry , Graft vs Host Disease/mortality , Graft vs Host Disease/pathology , Intestinal Diseases/pathology , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Lymphocytes/drug effects , Mice , Mice, Inbred C57BL , Splenomegaly , Thymic Factor, Circulating/pharmacology , Tissue Donors
16.
Eur J Immunol ; 27(12): 3427-37, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9464832

ABSTRACT

Stimulation of systemic antigen-specific IgE production plays an important role in the mediation of food allergy; however, the mechanism of IgE production against food antigens is not fully understood. The development of relevant animal models may help to elucidate the pathogenesis of food allergy. We here show that DBA/2 mice receiving a casein diet without any adjuvant produced high levels of IgE specific for casein, accompanied by predominant Th2-like responses in liver lymphocytes, mesenteric lymph node cells and spleen cells. This model of IgE production produced by feeding protein antigen as a constituent of the diet can be applied to investigate the mechanism of IgE production and to develop reagents for controlling food allergy.


Subject(s)
Antigens/immunology , Food Hypersensitivity , Immunoglobulin E/biosynthesis , Proteins/immunology , Th2 Cells/immunology , Animals , Antigens/administration & dosage , Diet , Immunoglobulin E/immunology , Mice , Mice, Inbred DBA , Proteins/administration & dosage
17.
Cell Immunol ; 171(1): 30-40, 1996 Jul 10.
Article in English | MEDLINE | ID: mdl-8660834

ABSTRACT

A significant fraction of murine small intestinal intraepithelial lymphocytes (i-IELs) mature in local sites outside the thymus. However, there is evidence suggesting that extrathymic differentiation of i-IELs is still influenced by the thymus or thymus-derived factors. Facteur thymique serique (FTS), a nonapeptide thymic hormone, is involved in several aspects of intra- and extrathymic T cell differentiation in vivo. In this study, we investigated the effects of FTS on the kinetics of i-IELs in mice following a single administration of 5-fluorouracil (5-FU). FTS treatment significantly accelerated the recovery in cell number of i-IELs after administration of 5-FU. Flow cytometric analysis revealed that this accelerated recovery was mainly due to a rapid increase in CD8 alpha alpha+ i-IELs. Similar findings were also evident in adult thymectomized (ATX) mice, indicating that FTS treatment caused a rapid recovery of CD8 alpha alpha+ i-IELs following 5-FU administration in the absence of a functional thymus. Furthermore, expression levels of the mRNAs for interleukin-2, interferon-gamma, and transforming growth factor beta 1 in the i-IELs were augmented by FTS treatment. Notably, FTS treatment protected mice from 5-FU-induced lethal toxicity, accompanied with an inhibition of the translocation of Enterobacteriaceae. These results suggest that FTS has an important function in the extrathymic maturation and activation of i-IELs in the small intestine following 5-FU administration, which may contribute at least partly to the protection against 5-FU-induced lethal toxicity.


Subject(s)
Fluorouracil/toxicity , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Lymphocyte Subsets/drug effects , Lymphocyte Subsets/immunology , Thymic Factor, Circulating/pharmacology , Animals , Cell Cycle/drug effects , Cell Cycle/immunology , Cytokines/biosynthesis , Cytokines/genetics , Epithelium/drug effects , Epithelium/immunology , Epithelium/pathology , Lymphocyte Subsets/pathology , Male , Mice , Mice, Inbred BALB C , RNA, Messenger/biosynthesis , RNA, Messenger/drug effects , Thymectomy , Thymic Factor, Circulating/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...